# Kaigene, Inc. — Form D

Kaigene, Inc. of BETHESDA, MD, a company, filed a Form D exempt-offering notice with the SEC on 2022-03-29. The offering totals $5.0M, of which $1.4M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2022-03-29
- Form: D
- Accession: 0001919055-22-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $1.4M
- Remaining: $3.6M
- Investors: 3
- Date of first sale: 2022-03-15
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-439447

## Issuer

- Name: Kaigene, Inc.
- CIK: 0001919055
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 12358 PARKLAWN DRIVE, BETHESDA, MD, 20850
- Phone: 301-655-8569

## Officers, directors & promoters (2)

| Name | Role | Location |
| --- | --- | --- |
| Minjae Shin | Director | BETHESDA, MD |
| Minjae Shin | Executive Officer | BETHESDA, MD |

## More

- [CIK 1919055 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1919055&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001919055-22-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.